Cargando…
Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome
Phelan-McDermid syndrome (PMS) is a genetic disorder often characterized by autism or autistic-like behavior. Most cases are associated with haploinsufficiency of the SHANK3 gene resulting from deletion of the gene at 22q13.3 or from a pathogenic variant in the gene. Treatment of PMS often targets S...
Autores principales: | Dyar, Brianna, Meaddough, Erika, Sarasua, Sara M., Rogers, Curtis, Phelan, Katy, Boccuto, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392667/ https://www.ncbi.nlm.nih.gov/pubmed/34440366 http://dx.doi.org/10.3390/genes12081192 |
Ejemplares similares
-
Phenotypic Variability in Phelan–McDermid Syndrome and Its Putative Link to Environmental Factors
por: Boccuto, Luigi, et al.
Publicado: (2022) -
Sleep and Phelan–McDermid Syndrome: Lessons from the International Registry and the scientific literature
por: Moffitt, Bridgette A., et al.
Publicado: (2022) -
Position effects of 22q13 rearrangements on candidate genes in Phelan-McDermid syndrome
por: Srikanth, Sujata, et al.
Publicado: (2021) -
Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor
por: Moffitt, Bridgette A., et al.
Publicado: (2023) -
Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations
por: Oberman, Lindsay M., et al.
Publicado: (2015)